Sifuvirtide, a potent HIV fusion inhibitor peptide
| Data(s) |
2009
|
|---|---|
| Resumo |
Enfuvirtide (ENF) is currently the only FDA approved HIV fusion inhibitor in clinical use. Searching for more drugs in this category with higher efficacy and lower toxicity seems to be a logical next step. In line with this objective, a synthetic peptide This work was supported in part by grants from the CAS (KSCX1-YW-R-15, 1(SCXI-YW-R-24) and 973 Program (2006CB504302, 2006CB504208, 2009CB5223006). We would like to acknowledge the MRC AIDS Research Project and the NIH AIDS Research and Reference Reagent |
| Identificador | |
| Direitos |
Sifuvirtide, a potent HIV fusion inhibitor peptide |
| Fonte |
Wang, Rui-Rui; Yang, Liu-Meng; Wang, Yun-Hua; Pang, Wei; Tam, Siu-Cheung; Tien, Po; Zheng, Yong-Tang.Sifuvirtide, a potent HIV fusion inhibitor peptide,382,540-544,Sifuvirtide; Enfuvirtide; Fusion inhibitor; HIV-1; Anti-HIV agents(SCI-E ):This work was supported in part by grants from the CAS (KSCX1-YW-R-15, 1(SCXI-YW-R-24) and 973 Program (2006CB504302, 2006CB504208, 2009CB5223006). We would like to acknowledge the MRC AIDS Research Project and the NIH AIDS Research and Reference Reagent |
| Palavras-Chave | #Biochemistry & Molecular Biology; Biophysics #Sifuvirtide #Enfuvirtide #Fusion inhibitor #HIV-1 #Anti-HIV agents |
| Tipo |
期刊论文 |
